| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
25,814 |
19,427 |
$2.87M |
| 99199 |
Unlisted special service, procedure or report |
93,239 |
53,084 |
$521K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,766 |
1,636 |
$141K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,477 |
1,304 |
$112K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,956 |
5,963 |
$68K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
811 |
708 |
$63K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,682 |
3,166 |
$57K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
736 |
638 |
$53K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,593 |
1,286 |
$42K |
| D0145 |
Oral evaluation for a patient under three years of age |
863 |
816 |
$30K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,592 |
2,389 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,699 |
1,477 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,457 |
1,245 |
$16K |
| D1206 |
Topical application of fluoride varnish |
874 |
827 |
$14K |
| 81003 |
|
3,022 |
1,777 |
$7K |
| 85018 |
|
1,353 |
1,205 |
$3K |
| 90474 |
|
338 |
277 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
64 |
37 |
$2K |
| 0012A |
|
39 |
37 |
$2K |
| 0011A |
|
61 |
49 |
$2K |
| 99381 |
|
28 |
24 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
172 |
161 |
$2K |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
121 |
85 |
$2K |
| 86308 |
|
274 |
261 |
$2K |
| 99401 |
|
115 |
70 |
$1K |
| 87807 |
|
121 |
97 |
$1K |
| 0071A |
|
86 |
46 |
$1K |
| 86403 |
|
92 |
89 |
$1K |
| 0072A |
|
47 |
30 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
55 |
44 |
$769.65 |
| 90686 |
|
1,177 |
949 |
$769.15 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
12 |
12 |
$497.75 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
109 |
96 |
$439.63 |
| 81025 |
|
83 |
60 |
$438.90 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
91 |
89 |
$393.77 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26 |
24 |
$313.19 |
| 82247 |
|
53 |
29 |
$249.48 |
| 90651 |
|
355 |
314 |
$185.01 |
| 99173 |
|
1,986 |
1,860 |
$167.54 |
| 92551 |
|
1,783 |
1,664 |
$166.57 |
| 81000 |
|
38 |
27 |
$141.04 |
| 90734 |
|
250 |
209 |
$138.18 |
| 90473 |
|
13 |
12 |
$107.63 |
| 87081 |
|
123 |
112 |
$87.96 |
| 90715 |
|
43 |
37 |
$75.10 |
| 96160 |
|
13 |
13 |
$51.09 |
| 83655 |
|
79 |
79 |
$31.55 |
| 81001 |
|
12 |
12 |
$8.06 |
| 90620 |
|
148 |
136 |
$0.01 |
| 90670 |
|
1,089 |
959 |
$0.00 |
| 90687 |
|
599 |
519 |
$0.00 |
| 90648 |
|
287 |
242 |
$0.00 |
| 90658 |
|
109 |
98 |
$0.00 |
| 90633 |
|
280 |
251 |
$0.00 |
| 90707 |
|
101 |
84 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
26 |
15 |
$0.00 |
| 80061 |
Lipid panel |
12 |
12 |
$0.00 |
| 90671 |
|
15 |
14 |
$0.00 |
| 90655 |
|
12 |
12 |
$0.00 |
| 91307 |
|
201 |
100 |
$0.00 |
| 90680 |
|
504 |
427 |
$0.00 |
| 90723 |
|
223 |
192 |
$0.00 |
| 90656 |
|
77 |
77 |
$0.00 |
| 90716 |
|
112 |
95 |
$0.00 |
| 91301 |
|
125 |
95 |
$0.00 |
| 90677 |
|
62 |
59 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
13 |
$0.00 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
163 |
155 |
$0.00 |
| 90688 |
|
210 |
186 |
$0.00 |
| 90647 |
|
300 |
286 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
28 |
27 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29 |
24 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
28 |
27 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
26 |
$0.00 |
| 90698 |
|
12 |
12 |
$0.00 |
| 99441 |
|
38 |
20 |
$0.00 |
| 90657 |
|
14 |
12 |
$0.00 |